Default company panoramic image

SynAm Vaccine

SynAm Vaccine’s mission is to eradicate pneumococcal diseases with the world’s first universal vaccine.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Rockville, MD, USA
  • Currency USD
  • Founded October 2000
  • Employees 2
  • Website

Company Summary

SynAm Vaccine is a unique vaccine biotech company that was founded by President/CEO, Dr. Don Chen. Focused on eradicating pneumococcal diseases that take the lives of 1.5M infants worldwide annually, the company has developed a universal vaccine that covers all 91 bacteria serotypes, meeting a critical unmet medical need in the marketplace.


  • Default avatar
    Don Chen

    Don Chen has 30 years experience in biomedical development, including basic research at the Mayo Clinic, industrial pharmaceutical research and development at CIBA‐GEIGY/Novartis, and regulation of new drugs, devices and biologics at the FDA. As a former FDA Regulatory Expert in Pharmacology/Toxicology, he has been an outside FDA Expert Consultant for ten years and is experienced in negotiations, deal‐making in the biopharmaceutical industry, an

  • Default avatar
    Carolyn Chen
    Vice President, Business Development

    Carolyn Chen is an accomplished professional in pharmaceutical and health care consulting, with expertise in business development strategy and marketing. She began her career at Towers Perrin, now Towers Watson, in New York. She also worked in the Corporate Affairs Division at Pfizer with responsibility for its global infectious disease programs. She has also worked at Médecins Sans Frontières/Doctors Without Borders in its neglected diseases


  • Default avatar
    Rubin & Rubin, PC (General); Occhiuti Rohlicek & Tsao LLP (Patent)
    Default avatar
    Yorke, Burke, & Lee, CPAs P.A.

Previous Investors

  • Default avatar
    47 friends and family individual investors
    Default avatar
    The Chemical Company of Malaysia